TORBICA, ALEKSANDRA
 Distribuzione geografica
Continente #
EU - Europa 10.470
NA - Nord America 5.143
AS - Asia 2.473
SA - Sud America 303
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 9
Totale 18.498
Nazione #
IT - Italia 6.370
US - Stati Uniti d'America 4.878
IE - Irlanda 964
CN - Cina 949
GB - Regno Unito 742
SG - Singapore 624
DE - Germania 412
UA - Ucraina 402
RU - Federazione Russa 308
BR - Brasile 257
SE - Svezia 250
NL - Olanda 244
CA - Canada 230
TR - Turchia 194
FR - Francia 176
HK - Hong Kong 174
FI - Finlandia 166
VN - Vietnam 142
IN - India 65
BG - Bulgaria 64
KR - Corea 63
IL - Israele 57
BE - Belgio 52
DK - Danimarca 49
ES - Italia 48
ID - Indonesia 48
AT - Austria 30
CZ - Repubblica Ceca 28
CH - Svizzera 27
RO - Romania 27
AL - Albania 26
TN - Tunisia 23
IR - Iran 19
EU - Europa 18
GR - Grecia 18
MX - Messico 18
PL - Polonia 18
TH - Thailandia 16
JP - Giappone 15
MA - Marocco 15
BD - Bangladesh 11
IQ - Iraq 11
PK - Pakistan 11
PT - Portogallo 11
SA - Arabia Saudita 11
AR - Argentina 10
EG - Egitto 10
AE - Emirati Arabi Uniti 9
ZA - Sudafrica 9
PH - Filippine 8
EC - Ecuador 7
LV - Lettonia 7
UZ - Uzbekistan 7
AU - Australia 6
AZ - Azerbaigian 6
PE - Perù 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
KZ - Kazakistan 5
NI - Nicaragua 5
BO - Bolivia 4
GE - Georgia 4
LK - Sri Lanka 4
LS - Lesotho 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
PA - Panama 4
UY - Uruguay 4
BY - Bielorussia 3
DZ - Algeria 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MW - Malawi 3
SM - San Marino 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BW - Botswana 2
CO - Colombia 2
EE - Estonia 2
KH - Cambogia 2
LY - Libia 2
MC - Monaco 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
GT - Guatemala 1
HN - Honduras 1
Totale 18.487
Città #
Milan 1.070
Dublin 958
Rome 675
Chandler 573
Ann Arbor 474
Houston 474
Southend 446
Ashburn 404
Hefei 366
Singapore 348
Jacksonville 330
New York 199
Beijing 196
Toronto 185
Hong Kong 167
The Dalles 167
Turin 148
Dearborn 142
Dong Ket 111
Frankfurt am Main 104
Wilmington 103
Naples 102
Helsinki 93
Lawrence 90
Boston 84
Boardman 82
Bologna 82
Moscow 80
Izmir 79
Modena 76
Los Angeles 66
Woodbridge 66
Mountain View 65
Florence 63
Seoul 63
Redwood City 55
Tel Aviv 55
Redmond 51
Genoa 50
Seattle 46
Munich 45
Jakarta 44
Padova 43
Brussels 42
Fairfield 40
Bari 39
Catania 33
Palermo 33
Verona 33
Brescia 31
Reggio Emilia 30
Washington 29
Palombara Sabina 28
Council Bluffs 26
Duncan 24
Nanjing 24
Cambridge 21
Dallas 21
Falls Church 21
Trieste 21
Assago 20
Taranto 20
Fremont 18
Nardò 18
Pescara 18
Bergamo 17
Treviso 17
London 16
San Francisco 16
São Paulo 16
Vienna 16
Latina 15
Perugia 15
Shanghai 15
Vicenza 15
Livorno 14
Ottawa 14
Paris 14
Parma 14
Pisa 14
Falkenstein 13
Jinan 13
Kunming 13
Lappeenranta 13
Monza 13
Napoli 13
Novara 13
Amsterdam 12
Chicago 12
Guangzhou 12
Hanoi 12
Norwalk 12
Sesto San Giovanni 12
Tokyo 12
Trento 12
Venice 12
Athens 11
Bucharest 11
Foggia 11
Nanchang 11
Totale 10.181
Nome #
Analisi dei costi della procedura angioplastica coronarica per via transradiale in regime ambulatoriale in Italia 5.248
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 356
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 334
Basic principles of health technology assessment, economic evaluation, and costing of healthcare programs 290
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 271
European Society of Cardiology: cardiovascular disease statistics 2019 266
Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano 237
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 234
Financing medical devices in Italy and Spain 214
Economic evaluation of medical devices 201
Systematic literature review on the spread of health-related misinformation on social media 197
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 195
The economic crisis and acute myocardial infarction: new evidence using hospital-level data 191
What factors drive heterogeneity of preferences for micro-health insurance in rural Malawi? 181
Understanding the impact of economic evidence on clinical decision making: a discrete choice experiment in cardiology 180
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 173
Diffusion without evidence: a study on high-risk medical devices 167
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 167
The role of hospital payments in the adoption of new medical technologies: an international survey of current practice 164
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 164
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data 157
Cost utility analysis of microprocessor controlled knee prosthesis in Italy 156
Epidemiology of cardiovascular disease in Europe 154
Funding and Regulating Health Technologies in Decentralized Systems: A Comparison between Italy and Spain 153
Learning effect and diffusion of innovative medical devices: the case of transcatheter aortic valve implantation in Italy 153
Sustainability of Universal Health Coverage: Five Continents, Four Perspectives 150
Key reccomendations from the MedtecHTA project 150
Challenges in the assessment of medical devices: the MedtecHTA Project 149
Direct costs of intracranial aneurysm treatment in the Italian hospitals 147
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 147
Comparing the efficiency of hospitals in Italy and Germany: nonparametric conditional approach based on partial frontier 144
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 143
HTA around the world: broadening our understanding of cross-country differences 142
Does informal care impact utilization of healthcare services? Evidence from a longitudinal study of stroke patients 141
Health care multidisciplinary teams: the sociotechnical approach for an integrated system-wide perspective 141
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project 140
Il governo regionale dell'assistenza farmaceutica: un quadro delle iniziative adottate nel 2003 138
Adoption decisions for medical devices in the field of cardiology: results from a European survey 137
Financing medical devices: The case of implantable cardioverter defibrillators and coronary stents in Italy 136
Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: un'applicazione del modello bootstrap 135
Inpatient reimbursement system in Italy: how do tariffs relate to costs? 134
Tariffe e finanziamento dell'innovazione tecnologica: analisi generale e focus su due casi regionali 134
Core outcome set in surgical oncology: why, what and how to measure 134
Impatto economico nella prospettiva del paziente: spese out-of-pocket, perdite di produttività e costi dell’assistenza informale 130
Cost and reimbursement of cataract surgery in Europe: a cross country comparison 129
Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy 127
Assessing the added value of health technologies: reconciling different perspectives 126
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 124
Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases 122
Traveling for care: Inter-regional mobility for aortic valve substitution in Italy 121
Should health technology assessment be more patient centric? If so, how? 121
At what cost is performance-based financing implemented? Novel evidence from Malawi 120
Investigating regional variation of cardiac implantable electrical device implant rates in European healthcare systems: what drives differences? 119
Costing and performance in healthcare management 119
Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? 119
Cost-effectiveness of a programme of screening and brief interventions for alchool in primary care in Italy 119
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 118
Economic evaluation of user-fee exemption policies for maternal healthcare in Burkina Faso: evidence from a cost-effectiveness analysis 117
Alcune riflessioni prima di tirare le somme 116
Facts. Figures! Fiction? 116
Incentivizing research into the effectiveness of medical devices 113
Coverage with evidence development for medical devices in Europe: can practice meet theory? 111
Explaining the health costs associated with managing intracranial aneurysms in Italy 110
Expanding the role of early health economic modelling in evaluation of health technologies. Comment on "Problems and promises of health technologies: the role of early health economic modeling" 107
Uptake and diffusion of medical technology innovation in Europe: what role for funding and procurement policies? 106
Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: prospective international cohort study 106
The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study 105
What criteria guide national entrepreneurs' policy decisions on user fee removal for maternal health care services? Use of a best-worst scaling choice experiment in West Africa. 103
European Union regulation of health technology assessment: what is required for it to succeed? 103
A new strategy for health and sustainable development in the light of the COVID-19 pandemic 102
Transformation of cancer care during and after the COVID pandemic, a point of no return : the experience of Italy 100
The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers 99
Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review 99
Equità territoriale: definizioni, evidenze empiriche e politiche appropriate 96
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 94
A cohort study on diabetic undocumented migrants in Italy: can charitable organizations contribute to higher adherence? 89
Economic Evaluation in Health Care: the Point of View of Informed Physicians 87
Hospital cost of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy 86
Eliciting preferences to inform patient-centered policies: the case of psoriasis 85
Inequalities in avoidable hospitalisation in large urban areas: retrospective observational study in the metropolitan area of Milan 84
Healthcare services for undocumented migrants : organisation and costs from the Italian NHS perspective 83
Evaluating complex health financing interventions: using mixed methods to inform further implementation of a novel PBI intervention in rural Malawi 82
Prioritizing COVID-19 vaccine allocation in resource poor settings: towards an Artificial Intelligence-enabled and geospatial-assisted decision support framework 80
Blood donation in times of crisis: early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries 80
Economic burden of cardiovascular diseases in the European Union: a population-based cost study 73
Eliciting community preferences for complementary micro health insurance: A discrete choice experiment in rural Malawi. 71
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 71
Risk communication during COVID-19: a descriptive study on familiarity with, adherence to and trust in the WHO preventive measures 71
Fact: Frailty can be prevented and treated 69
A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy 66
How real can we get in generating real world evidence? Exploring the opportunities of routinely collected administrative data for evaluation of medical devices 66
Longitudinal associations between different measures of socioeconomic status and health behavior among adolescents. Data from a wealthy Italian region 64
Real-world evidence in health technology assessment of high-risk medical devices: fit for purpose? 64
Investigating patients’ preferences to inform drug development decisions: novel Insights from a discrete choice experiment in migraine 63
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges 61
Public preferences for vaccination campaigns in the COVID-19 endemic phase: insights from the VaxPref database 60
Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: an analysis of drug-eluting stents in Germany and Italy 59
Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries 59
The role of technology and social media use in sleep-onset difficulties among Italian adolescents: cross-sectional study 58
Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR council report 55
Totale 18.148
Categoria #
all - tutte 68.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.599 0 140 89 175 198 153 160 64 158 126 134 202
2021/20221.635 79 209 54 59 119 63 100 197 150 188 205 212
2022/20233.744 234 222 103 300 242 274 180 264 1.341 167 248 169
2023/20243.050 175 139 188 150 239 382 317 327 158 241 362 372
2024/20254.398 247 131 305 273 302 290 409 329 1.003 442 398 269
2025/20261.087 735 352 0 0 0 0 0 0 0 0 0 0
Totale 18.831